Myeloma


January 31, 2018

International Expert at UAMS Myeloma Institute Releases First Book on Castleman Disease

Frits van Rhee, M.D., Ph.D., professor of medicine and director of developmental and translational medicine at the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS), has changed that.

November 30, 2017

Multiple Myeloma: A Rare and Complex Cancer

We continue our series on multiple myeloma with an interview with Gareth J. Morgan, MD, FRCP, FRCPath, PhD, professor of hematology and director of the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS). Dr. Morgan also serves as deputy director of the Winthrop P. Rockefeller Cancer Institute at UAMS.


October 10, 2017

UAMS Study Identifies One Reason Myeloma Patients Respond Differently to Treatment

Niels Weinhold, Ph.D., (left) and Leo Rasche, M.D., researchers with the UAMS Myeloma Institute, leading a team in a study of 51 myeloma patients, have discovered patients respond differently to treatment because cancer cells can vary depending on their location. The team’s findings, which underscore the need to explore more than the standard biopsy site of the upper, outer edge of the pelvis, were recently published in an article in Nature Communications.

Oct. 10, 2017 | Researchers with the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) have identified one reason myeloma patients respond differently to treatment — the cancer cells can vary in type and intensity depending on where in the bone marrow they are located. The team headed by Leo Rasche, M.D., and Niels Weinhold, Ph.D.,…